This Is Only A Test, Part One: The Glamorous and Exotic World of Clinical Trials

[audio mp3="https://pdcn.co/e/rss.art19.com/episodes/169e9ac8-3007-4623-95c1-d419e368f642.mp3?rss_browser=BAhJIgljdXJsBjoGRVQ%3D--435795d5c850773aaa4739d968bd77a1dfd6f301"][/audio] This Is Only A Test, Part One: The Glamorous and Exotic World of Clinical Trials

How does one "Schoolhouse Rock" the interesting world of Clinical Trials? On the show, Matthew and his Co-Founder/COO Andrew MacDowell are joined by Medaptive Health’s co-founders Eric Kroll and Jeremy Block to help break down and de-jargon what exactly is going on in the world of trials, patient advocacy, drug approvals — and the ever evolving role of Industry, for better or for worse.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kenny Kane

Kenny Kane is an entrepreneur, writer, and nonprofit innovator with 15+ years of experience leading organizations at the intersection of business, technology, and social impact. He is the CEO of Firmspace, CEO of the Testicular Cancer Foundation, and CTO/co-founder of Gryt Health.

A co-founder of Stupid Cancer, Kenny has built national awareness campaigns and scaled teams across nonprofits, health tech, and real estate. As an author, he writes about leadership, resilience, and building mission-driven organizations.

Previous
Previous

This Is Only A Test, Part Two: The Glamorous and Exotic World of Clinical Trials

Next
Next

Relentless: John Tesh on Music, Cancer, Grit, and Faith